These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8298987)

  • 1. Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease.
    Tejani-Butt SM; Yang J; Zaffar H
    Brain Res; 1993 Dec; 631(1):147-50. PubMed ID: 8298987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei.
    Ordway GA; Stockmeier CA; Cason GW; Klimek V
    J Neurosci; 1997 Mar; 17(5):1710-9. PubMed ID: 9030630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of humans.
    Tejani-Butt SM; Ordway GA
    Brain Res; 1992 Jun; 583(1-2):312-5. PubMed ID: 1504838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.
    Klimek V; Stockmeier C; Overholser J; Meltzer HY; Kalka S; Dilley G; Ordway GA
    J Neurosci; 1997 Nov; 17(21):8451-8. PubMed ID: 9334417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
    Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
    Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
    Szot P; White SS; Greenup JL; Leverenz JB; Peskind ER; Raskind MA
    J Neurosci; 2006 Jan; 26(2):467-78. PubMed ID: 16407544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporters in rat placenta labeled with [3H]nisoxetine.
    Shearman LP; Meyer JS
    J Pharmacol Exp Ther; 1998 Feb; 284(2):736-43. PubMed ID: 9454822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease.
    Szot P; Leverenz JB; Peskind ER; Kiyasu E; Rohde K; Miller MA; Raskind MA
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):135-40. PubMed ID: 11113540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.
    Zavosh A; Schaefer J; Ferrel A; Figlewicz DP
    Brain Res Bull; 1999 Jul; 49(4):291-5. PubMed ID: 10424850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter.
    Jayanthi LD; Prasad PD; Ramamoorthy S; Mahesh VB; Leibach FH; Ganapathy V
    Biochemistry; 1993 Nov; 32(45):12178-85. PubMed ID: 8218295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine up-regulates norepinephrine transporter binding in the rat placenta.
    Shearman LP; Meyer JS
    Eur J Pharmacol; 1999 Dec; 386(1):1-6. PubMed ID: 10611457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
    Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
    J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors.
    Zhu MY; Ordway GA
    J Neurochem; 1997 Jan; 68(1):134-41. PubMed ID: 8978719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding.
    Tejani-Butt SM
    J Pharmacol Exp Ther; 1992 Jan; 260(1):427-36. PubMed ID: 1731049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine binding to the rat norepinephrine transporter in vivo.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2000 May; 47(9):842-5. PubMed ID: 10812044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment.
    Szot P; Ashliegh EA; Kohen R; Petrie E; Dorsa DM; Veith R
    Brain Res; 1993 Aug; 618(2):308-12. PubMed ID: 8374761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake.
    Gehlert DR; Hemrick-Luecke SK; Schober DA; Krushinski J; Howbert JJ; Robertson DW; Wong DT; Fuller RW
    Life Sci; 1995; 56(22):1915-20. PubMed ID: 7746100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
    Sucic S; Bryan-Lluka LJ
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.